ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk

October 28, 2005

Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala

June 18, 1993

DeVita Asks Panel’s Assistance On Personnel Ceilings, Construction, New NCAB Appointments

December 9, 1983